Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques. 1996

J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
First Department of Surgery, Kinki University School of Medicine, Osaka, Japan.

OBJECTIVE The usefulness of postoperative carcinoembryonic antigen (CEA) monitoring and improvements in imaging techniques have renewed enthusiasm for second-look operations (SLO) as the most effective treatment for recurrent colorectal cancer by reresection following early detection. The aim of our study is to evaluate the role of CEA and imaging techniques-directed SLO. METHODS Seven hundred fifty-six patients with Dukes Stages B and C, who had undergone curative resection, were monitored postoperatively using CEA and imaging techniques. An SLO was performed on any potentially resectable recurrence, and in addition, an SLO was done when a persistently rising CEA value was detected. RESULTS Recurrence developed in 18.8 percent (142/756) of patients, and 90.8 percent (129/142) of the recurrences were detected within the first three years following curative resection. When comparing carcinomas of the colon with that of the rectum, the former were associated with significantly more hepatic and intraabdominal recurrences, whereas the latter had significantly more locoregional and pulmonary recurrences. Seventy-two patients underwent SLO. Of these patients, 54.2 percent (39/72) had all of their disease resected, and 1.4 percent (1/72) had no detectable disease at the SLO. Among the 142 patients with recurrence, 71 (50 percent) patients underwent SLO. The resectable group at SLO carried a significantly better survival than the unresectable recurrence group (41.3 vs. 5.2 percent; P<0.01). CONCLUSIONS Complete removal of colorectal cancer recurrences by SLO, on the basis of postoperative, follow-up CEA and imaging technique findings, results in improved survival.

UI MeSH Term Description Entries
D008297 Male Males
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000206 Actuarial Analysis The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs. Analysis, Actuarial,Actuarial Analyses,Analyses, Actuarial
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
September 1982, La Nouvelle presse medicale,
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
February 1986, Gut,
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
September 1985, The British journal of surgery,
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
May 2014, BMJ open,
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
March 1985, Cancer,
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
January 1996, Digestive diseases (Basel, Switzerland),
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
February 1985, American journal of surgery,
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
April 1978, Diseases of the colon and rectum,
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
November 1988, Revista espanola de las enfermedades del aparato digestivo,
J Hida, and M Yasutomi, and K Shindoh, and M Kitaoka, and K Fujimoto, and S Ieda, and N Machidera, and R Kubo, and E Morikawa, and H Inufusa, and M Watatani, and K Okuno
January 1978, Journal of surgical oncology,
Copied contents to your clipboard!